State Street Corp Eliem Therapeutics, Inc. Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
A detailed history of State Street Corp transactions in Eliem Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 59,007 shares of ELYM stock, worth $293,854. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,007
Previous 21,700
171.92%
Holding current value
$293,854
Previous $59,000
610.17%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ELYM
# of Institutions
46Shares Held
49.9MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA31.4MShares$156 Million3.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.9MShares$19.4 Million0.91% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.26MShares$16.2 Million11.93% of portfolio
-
Janus Henderson Group PLC London, X03.25MShares$16.2 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA2.6MShares$13 Million1.03% of portfolio
About Eliem Therapeutics, Inc.
- Ticker ELYM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,567,700
- Market Cap $132M
- Description
- Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...